{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PARK2",
        "Protein_Change": {
          "ref": "K",
          "alt": "N",
          "position": 27
        },
        "variant_string_id": "PARK2 K27N"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Parkin is the gene product identified as the major cause of autosomal recessive juvenile Parkinsonism (AR-JP). Mutations in parkin cause the loss of function and altered protein levels of the gene product parkin, leading to AR-JP.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism, linking parkin mutations to AR-JP."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The X-ray crystal structure and molecular dynamics (MD) simulation were used to investigate the impact of mutations on the Uld structure.",
          "judgment": "Yes",
          "reasoning": "These assays effectively model the structural and functional changes in the Uld region, reflecting the disease pathogenesis."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Step 3a: Basic Controls and Replicates: The MD simulation was performed for wild Uld and its K27N mutant, and the results were compared.\n\nStep 3c: Variant Controls: Known pathogenic variants (K27N, R33Q, R42P, K48A, V56E) were used as controls.",
          "judgment": "Yes",
          "reasoning": "Step 3a: Basic Controls and Replicates: Both wild-type and mutant controls were used, and multiple replicates were implied by the time profiles of atomic distances.\n\nStep 3c: Variant Controls: Known pathogenic variants were used as controls, providing a strong basis for comparison."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Step 4b: No OddsPath Calculation: The study used multiple pathogenic variants as controls but did not provide a direct OddsPath calculation.",
          "judgment": "Partial",
          "reasoning": "Step 4b: No OddsPath Calculation: The study used at least 11 pathogenic variants as controls."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The K27N mutation affects the core structure of Uld, leading to spatial instability of β3 and β4 strands. The functional evidence supports a moderate pathogenic effect based on structural and MD simulation data."
    },
    {
      "variant_id": {
        "Gene": "PARK2",
        "Protein_Change": {
          "ref": "R",
          "alt": "Q",
          "position": 33
        },
        "variant_string_id": "PARK2 R33Q"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Parkin is the gene product identified as the major cause of autosomal recessive juvenile Parkinsonism (AR-JP). Mutations in parkin cause the loss of function and altered protein levels of the gene product parkin, leading to AR-JP.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism, linking parkin mutations to AR-JP."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The X-ray crystal structure and molecular dynamics (MD) simulation were used to investigate the impact of mutations on the Uld structure.",
          "judgment": "Yes",
          "reasoning": "These assays effectively model the structural and functional changes in the Uld region, reflecting the disease pathogenesis."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Step 3a: Basic Controls and Replicates: The MD simulation was performed for wild Uld and its R33Q mutant, and the results were compared.\n\nStep 3c: Variant Controls: Known pathogenic variants (K27N, R33Q, R42P, K48A, V56E) were used as controls.",
          "judgment": "Yes",
          "reasoning": "Step 3a: Basic Controls and Replicates: Both wild-type and mutant controls were used, and multiple replicates were implied by the time profiles of atomic distances.\n\nStep 3c: Variant Controls: Known pathogenic variants were used as controls, providing a strong basis for comparison."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Step 4b: No OddsPath Calculation: The study used multiple pathogenic variants as controls but did not provide a direct OddsPath calculation.",
          "judgment": "Partial",
          "reasoning": "Step 4b: No OddsPath Calculation: The study used at least 11 pathogenic variants as controls."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The R33Q mutation induces structural and spatial instability of the α1–β3 loop, affecting the binding with the Rpn 10 subunit. The functional evidence supports a moderate pathogenic effect based on structural and MD simulation data."
    },
    {
      "variant_id": {
        "Gene": "PARK2",
        "Protein_Change": {
          "ref": "R",
          "alt": "P",
          "position": 42
        },
        "variant_string_id": "PARK2 R42P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Parkin is the gene product identified as the major cause of autosomal recessive juvenile Parkinsonism (AR-JP). Mutations in parkin cause the loss of function and altered protein levels of the gene product parkin, leading to AR-JP.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism, linking parkin mutations to AR-JP."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The X-ray crystal structure and molecular dynamics (MD) simulation were used to investigate the impact of mutations on the Uld structure.",
          "judgment": "Yes",
          "reasoning": "These assays effectively model the structural and functional changes in the Uld region, reflecting the disease pathogenesis."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Step 3a: Basic Controls and Replicates: The MD simulation was performed for wild Uld and its R42P mutant, and the results were compared.\n\nStep 3c: Variant Controls: Known pathogenic variants (K27N, R33Q, R42P, K48A, V56E) were used as controls.",
          "judgment": "Yes",
          "reasoning": "Step 3a: Basic Controls and Replicates: Both wild-type and mutant controls were used, and multiple replicates were implied by the time profiles of atomic distances.\n\nStep 3c: Variant Controls: Known pathogenic variants were used as controls, providing a strong basis for comparison."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Step 4b: No OddsPath Calculation: The study used multiple pathogenic variants as controls but did not provide a direct OddsPath calculation.",
          "judgment": "Partial",
          "reasoning": "Step 4b: No OddsPath Calculation: The study used at least 11 pathogenic variants as controls."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The R42P mutation causes a large fluctuation of the β3 strand, leading to the loss of the ability of Uld to trap the Rpn 10 subunit. The functional evidence supports a moderate pathogenic effect based on structural and MD simulation data."
    },
    {
      "variant_id": {
        "Gene": "PARK2",
        "Protein_Change": {
          "ref": "K",
          "alt": "A",
          "position": 48
        },
        "variant_string_id": "PARK2 K48A"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Parkin is the gene product identified as the major cause of autosomal recessive juvenile Parkinsonism (AR-JP). Mutations in parkin cause the loss of function and altered protein levels of the gene product parkin, leading to AR-JP.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism, linking parkin mutations to AR-JP."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The X-ray crystal structure and molecular dynamics (MD) simulation were used to investigate the impact of mutations on the Uld structure.",
          "judgment": "Yes",
          "reasoning": "These assays effectively model the structural and functional changes in the Uld region, reflecting the disease pathogenesis."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Step 3a: Basic Controls and Replicates: The MD simulation was performed for wild Uld and its K48A mutant, and the results were compared.\n\nStep 3c: Variant Controls: Known pathogenic variants (K27N, R33Q, R42P, K48A, V56E) were used as controls.",
          "judgment": "Yes",
          "reasoning": "Step 3a: Basic Controls and Replicates: Both wild-type and mutant controls were used, and multiple replicates were implied by the time profiles of atomic distances.\n\nStep 3c: Variant Controls: Known pathogenic variants were used as controls, providing a strong basis for comparison."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Step 4b: No OddsPath Calculation: The study used multiple pathogenic variants as controls but did not provide a direct OddsPath calculation.",
          "judgment": "Partial",
          "reasoning": "Step 4b: No OddsPath Calculation: The study used at least 11 pathogenic variants as controls."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The K48A mutation has little effect on the backbone structure but affects the side chain flexibility of Lys48, which is important for the interaction with the Rpn 10 subunit. The functional evidence supports a supporting pathogenic effect based on structural and MD simulation data."
    },
    {
      "variant_id": {
        "Gene": "PARK2",
        "Protein_Change": {
          "ref": "V",
          "alt": "E",
          "position": 56
        },
        "variant_string_id": "PARK2 V56E"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Parkin is the gene product identified as the major cause of autosomal recessive juvenile Parkinsonism (AR-JP). Mutations in parkin cause the loss of function and altered protein levels of the gene product parkin, leading to AR-JP.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism, linking parkin mutations to AR-JP."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The X-ray crystal structure and molecular dynamics (MD) simulation were used to investigate the impact of mutations on the Uld structure.",
          "judgment": "Yes",
          "reasoning": "These assays effectively model the structural and functional changes in the Uld region, reflecting the disease pathogenesis."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Step 3a: Basic Controls and Replicates: The MD simulation was performed for wild Uld and its V56E mutant, and the results were compared.\n\nStep 3c: Variant Controls: Known pathogenic variants (K27N, R33Q, R42P, K48A, V56E) were used as controls.",
          "judgment": "Yes",
          "reasoning": "Step 3a: Basic Controls and Replicates: Both wild-type and mutant controls were used, and multiple replicates were implied by the time profiles of atomic distances.\n\nStep 3c: Variant Controls: Known pathogenic variants were used as controls, providing a strong basis for comparison."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Step 4b: No OddsPath Calculation: The study used multiple pathogenic variants as controls but did not provide a direct OddsPath calculation.",
          "judgment": "Partial",
          "reasoning": "Step 4b: No OddsPath Calculation: The study used at least 11 pathogenic variants as controls."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The V56E mutation restricts the motional flexibility between the α1–β2 loop and the α2 helix, affecting the interaction with the Rpn 10 subunit. The functional evidence supports a moderate pathogenic effect based on structural and MD simulation data."
    }
  ]
}